Saturday, May 02, 2020 11:14:47 PM
It's really not enough people to make a real determination on, but it's an interesting thought.
The CLI Trial is proceeding, but apparently slowed by coronavirus, like our lives. In time the trial will conclude, the drug will be approved, and if it's not already approved for pneumonia, it can be used for it off label. I frankly believe it will have benefits for all sorts of things, CLI just happens to be the first to be tested by the company. My leukemia treatment does create some neuropathy, I don't doubt that it could be of benefit with it. Once it's achieve approval I believe we'll see it tried in all sorts of things, and anecdotal evidence will show what it works for, and perhaps what it doesn't.
Gary
FEATURED Southern Silver Files NI43-101 Technical Report for its Updated Preliminary Economic Assessment for the Cerro Las Minitas Project • Jul 25, 2024 8:00 AM
Greenlite Ventures Completes Agreement with No Limit Technology • GRNL • Jul 19, 2024 10:00 AM
VAYK Expects Revenue from First Airbnb Property Starting from August • VAYK • Jul 18, 2024 9:00 AM
North Bay Resources Acquires Mt. Vernon Gold Mine, Sierra County, California, with Assays up to 4.8 oz. Au per Ton • NBRI • Jul 18, 2024 9:00 AM
Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com • NGTF • Jul 17, 2024 1:00 PM
Kona Gold Beverages Reaches Out to Largest Debt Holder for Debt Purchase Negotiation • KGKG • Jul 17, 2024 9:00 AM